Conferences and Events
Up-coming EGA Conferences
Coming up in 2012
Brussels | 22-23 March 2012
8th EGA Legal Affairs Forum
Recent developments on SPCs:
• SPCs caselaw and legislation update:
- The galanthamine and the memantine decisions
- The Medeva and the Georgetown references to the CJEU
- Paediatric extensions: negative term SPCs
• Combination products in the pipeline - the effect of the Medeva judgment
• Litigating SPCs around Europe - escitalopram case study:
- What is the product/active ingredient? Regulatory and litigation strategies
• Roundtable presentations on national escitalopram SPC cases: Germany, France, The Netherlands, Belgium
Maximising legal professional privilege:
• Privilege in litigation in Europe (General overview, comparing approach in different Member States)
• US perspective on Privilege (US approach to privilege and discovery, issues with cross-border communications in “touch base” rules vs comity rules, practical guidelines for litigants/potential litigants)
• Privilege and European Commission investigations/patent settlement cases (The Akzo Nobel case, practical issues arising from investigations - privilege and disclosure, update on the Commission’s investigations into patent settlements)
Patent enforcement in Europe:
• Views on the review of Directive 2004/48/EC on the enforcement of IP rights
• Views on the changes in the EU patent system: single court and patent with unitary effect
• Update on court cases that impact the industry
Full programme - Register now - Click here for Advertising Exhibition and Sponsorship Opportunities
London | 19-20 April 2012
10th EGA International Symposium on Biosimilar Medicines
with EGA Pre-symposium Workshop "Biosimilars in America: IP Strategy and Due Diligence"
FOR A DECADE, THE PREMIER EU EVENT ON BIOSIMILAR MEDICINES!
Come and meet the EU and international regulators and the leading EU companies in biosimilars.
The pre-symposium workshop will explore the mechanics of the Biologics Act with an emphasis on how the Act relates to the involved intellectual property and how the intellectual property may impact the biosimilar applicant’s strategy for entering the market.
SYMPOSIUM HIGHLIGHTS 2012:
• Get the IMS outlook on the biotechnology and biosimilars global market and its opportunities. • Become familiar with the roadmap for an EU policy for biosimilars.
• Hear the investors’ insights into mergers & acquisitions and the financial market perspective of the biosimilars market.
• Exchange views on the experience with the national uptake of biosimilars.
• Get a detailed update from the EU regulators on the revised biosimilar guidelines and the adopted biosimilar monoclonal antibodies guideline.
• Learn about the latest status of the US FDA biosimilar guidelines and the developments in Japan and major Latin American countries.
• Join the discussion on the need for a framework supporting global development for biosimilars.
• Come and meet regulators from all over the world and take advantage of networking opportunities within the biosimilar industry.
Full programme - Register now - Click here for Advertising Exhibition and Sponsorship Opportunities
Malta | 13-15 June 2012
18th EGA Annual Conference "Healthy and Active Ageing Through Improved Access to Affordable Generic Medicines"
• KEYNOTE SPEECH - The European Union's vision in the European year for active ageing and solidarity between generations - Commissioner John Dalli, European Commissioner for Health and Consumers
• Society undergoing transformation: how to better match the medicine needs of society and improve healthcare sustainability.
• Price cuts, tendering systems, price reference systems: the way forward to a sustainable generic medicines industry.
• How can European generic and biosimilar medicines companies succeed in a changing world?
• The EU regulatory environment impacting access to generic and biosimilar medicines.
• Future scenarios for the generic and biosimilar medicines industry: viewpoints from analysts.
• CEO PANEL – What is the future of the EU generic and biosimilar medicines industry in the period of global economic upheaval and demographic changes: the views of CEOs from leading generic and biosimilar medicines companies.
More info click here - Click here for Advertising Exhibition and Sponsorship Opportunities
Brussels | 27-28 June 2012
"Quality by design for generic medicines: Building a successful Business Case"- Joint ISPE – EGA Conference
This event is the first in Europe to focus on the practical application of the concept of Quality by Design (QbD) to the pharmaceutical development and manufacturing of generic medicines.
It will offer a unique discussion platform for the generic medicines industry and regulators to gain essential updates and clarification on technical elements of QbD, as well as QbD’s regulatory and compliance implications. Registrations will open 15 February 2012 on www.ispe.org/2012QbDeuconference
London | 6 November 2012
4th EMA—EGA Information Day
- EGA Members only
IGPA Conferences
Japan | TBC 2012
15th Annual IGPA Conference More info available by the end of 2011
Europe | TBC 2013
16th Annual IGPA Conference More info available by the end of 2012
Past EGA & IGPA Events
2012
London | 18 January 2012
5th EGA Pharmacovigilance Discussion Forum
London | 18 January 2012
7th EGA South East European Pharmaceutical Symposium "Meeting the European Challenge for National Drug Regulatory Agencies and the Generic Medicines Industry" - EGA Members only
London | 19-20 January 2012
11th EGA Regulatory and Scientific Affairs Conference "Meeting New Challenges of the Regulatory Environment"
2011
Cape Town (South Africa) | 1-3 November 2011
14th Annual IGPA Conference
Lisbon - Cascais | 15-17 June 2011
17th EGA Annual Conference
London | 14-15 April 2011
9th EGA International Symposium on Biosimilar Medicines
Brussels | 17-18 March 2011
7th EGA Legal Affairs Forum with an Opening Session on SPCs
London | 24 January 2011
4th EGA Pharmacovigilance Discussion Forum
London | 25-26 January 2011
10th EGA Regulatory and Scientific Affairs Conference
2010
Mumbai | 8-10 December 2010
13th Annual IGPA Conference More info info@ipa-india.org
Suntec City - Singapore | 27 November 2010
IABS IFPMA and EGA Workshop on Biologicals
"Challenges in Evaluating Similar Biotherapeutic Products"
London | 10 November 2010
3rd EMA—EGA Information Day
Vrsac, Serbia | 30 September - 1 October 20106th EGA South East European Pharmaceutical Symposium
London | 2-3 September 2010
Biosimilar Medicines: 8th EGA Annual International
Symposium
Rome | 2-4 June 2010 with Welcome Cocktail on 2 June 2010
16th EGA Annual Conference
London | 1 June 2010
3rd EGA Symposium on Bioequivalence
Munich | 11 March 2010
6th EGA Legal Affairs Forum
London | 21-22 January 2010
9th EGA Regulatory and Scientific Affairs Conference
London | 20 January 2010
MHRA-BGMA-EGA Info Day
London | 20 January 2010
3rd EGA Pharmacovigilance Discussion Forum
2009
Montreal | 30 September - 2 October 2009
12th Annual IGPA Conference

Ohrid, Macedonia (FYROM) | 24-25 September 2009
5th EGA SE Europe Pharmaceutical Symposium
Barcelona | 3-5 June 2009
15th EGA Annual Conference 2009
London | 23–24 April 2009
7th EGA Annual Symposium on Biosimilar Medicines
“Towards Global Development and Monoclonal Antibodies”
Munich | 12-13 March 2009
5th EGA Legal Affairs Forum
Amsterdam | 28 January 2009
MEB-EGA Info Day
Amsterdam | 28 January 2009
2nd EGA Pharmacovigilance Discussion Forum
Amsterdam | 29–30 January 2009
8th EGA Regulatory and Scientific Affairs Conference
2008
Geneva | 8-10 December 2008
11th
IGPA Annual Conference
Paris | 7-8 October 2008
2nd EGA-CMD(h) Symposium on Bioequivalence
“Bioequivalence guideline revision, regulatory procedures and
good practices: paving the way towards an even more efficient regulatory framework”
London: 3 October 2008
2nd
EMEA—EGA Info Day | For EGA Members Only
“Generic &
Biosimilar Medicines in the Centralised Procedure”
Paris | 4 June 2008
AFSSAPS—EGA Information Day
Paris | 2-3 June 2008
14th EGA Annual Conference
“Generic Medicines | Enhancing Pharmaceutical Competition
and Ensuring Healthcare Sustainability”
London | 24–25 April 2008
6th EGA Symposium on Biosimilar Medicines
“Biosimilar Medicines | Developing Market Pathways
that Benefit Patients”
Brussels: 31 Jan–1 Feb 2008
7th EGA Regulatory & Scientific Affairs Conference
“Developing an Efficient Regulatory System in Europe”
Brussels: 30 January 2008
4th EGA Legal Affairs Forum
Brussels: 30 January 2008
1st EGA Pharmacovigilance Forum
“EU Pharmacovigilance: A Moving Target”
2007
Miami: 28 Nov-1 Dec 2007
10th IGPA Annual Conference
“Generic Medicines: A Global Market - A Global Industry”
Lisbon: 23-24 October 2007
1st EGA Workshop on Bioequivalence
“Study Design, Working to GCP and Interpreting the Guidelines: The Keys to a Successful Generics Application”
Istanbul: 14-16 June 2007
13th EGA Annual Conference
“Challenges in the European and Global Environment
for the
Generic Medicines Industry”
London: 3-4 May 2007
5th EGA Symposium on Biosimilars
“BIOSIMILAR MEDICINES: Opportunity for Sustainable Healthcare”
- THE biosimilars event of the year!
Brussels: 13-14 February 2007
6th EGA Regulatory Affairs Conference
Incorporating: 12 February 2007
3rd EGA Legal Affairs Forum
2006
London: 24 November 2006
EMEA—EGA Info Day
“Generic and Biosimilar Medicines in the Centralised Procedure”
Budapest: 21-22 September 2006
12th EGA Annual Conference
Monaco (Nice): 18-21 June 2006
9th Annual IGPA International Generics Conference 2006
London: 18-19 May 2006
4th EGA Annual Symposium on Biosimilars
“Biosimilar Products, a Reality in Europe”
London: 2-3 February 2006
5th EGA Regulatory Affairs Conference
Incorporating
London: 1 February 2006
» 2nd EGA Legal Affairs Forum
in parallel with
» Pre-Conference Seminar: How to approach electronic submissions with eCTD?
2005
Berlin: 21-22 November 2005
11th EGA Annual Conference
Malta: 19-22 June 2005
8th Annual IGPA International
Generics Conference 2005
London: 26-27 May 2005
3rd Annual EGA Symposium
on “BIOGENERICS”
London: 2/3-4 February 2005
4th EGA Regulatory Affairs
Conference and
1st EGA Legal Affairs Forum
- Programme Details for both Events
2004
Lisbon: 26 November 2004
1° Encontro Ibérico de Medicamentos Genéricos
Organised by APOGEN in collaboration with EGA
- Opening Keynote Address
Luís Filipe Pereira, Portuguese Minister for Health [PT] [EN]
- APOGEN Press Release [PT] [EN]
- Conference Programme [PT]
Amsterdam: 8-9 November 2004
10th EGA Annual Conference
“Meeting the Challenge”
Prague: 28-30 June 2004
7th Annual IGPA
International Generics Conference
London: 28 May 2004
2nd EGA Symposium on “Biogenerics”
London: 12-13 February 2004
3rd Annual EGA Regulatory Affairs Conference 2004
2003
Rome: 10-11 November 2003
9th Annual EGA Conference:
“Increasing Patient Access to Affordable Generic Medicines in an Expanding European Union”
Lisbon: 30 June-2 July 2003
6th Annual IGPA International Generics Conference
London: 23 May 2003
1st EGA Symposium on “Biotech Generics”
Brussels: 13-14 March 2003
2nd Annual EGA Regulatory Affairs Conference
2002
Copenhagen: 19-20 September 2002
8th Annual EGA Conference
“Generic Medicines: Overcoming the Barriers to Generic Competition in Europe’s Healthcare Market”
Florida, USA: 8-12 April 2002
5th Annual IGPA International Generics Conference
Programme not available.
London: 14-15 February 2002
1st Annual EGA Regulatory Affairs Conference
2001
Brussels: 20-21 November 2001
7th Annual EGA Conference
“Generic Medicines: Encouraging Competition & Affordability In Europe’s Healthcare Market”
2000
Krakow: 4-6 October 2000
6th Annual EGA Conference
|